Nurix Therapeutics

ISIN US67080M1036

 | 

WKN A2P85Z

Market cap (in EUR)
1,707 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.
Show more Show less
Healthcare Biopharmaceuticals Other Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 1,707 m
EPS, EUR -2.70
P/B ratio 4.0
P/E ratio -
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 50 m
Net income, EUR -178 m
Profit margin -354.85%

What ETF is Nurix Therapeutics in?

There are 24 ETFs which contain Nurix Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Nurix Therapeutics is the ARK Genomic Revolution UCITS ETF USD Accumulating.
ETF Weight Investment focus Fund size (in m EUR)
Amundi MSCI World Small Cap ESG Broad Transition UCITS ETF Acc 0.01%
Equity
World
Small Cap
Climate Change
 -
UBS MSCI USA Select Factor Mix UCITS ETF hEUR acc 0.00%
Equity
United States
Multi-Factor Strategy
 9
SPDR MSCI All Country World Investable Market UCITS ETF (Acc) 0.00%
Equity
World
 3,891
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF EUR Acc 0.02%
Equity
United States
Small Cap
 36
UBS MSCI USA Select Factor Mix UCITS ETF USD acc 0.00%
Equity
United States
Multi-Factor Strategy
 98
SPDR MSCI World Small Cap UCITS ETF 0.01%
Equity
World
Small Cap
 1,383
Xtrackers Portfolio UCITS ETF 1C 0.00%
Equity
World
Multi-Asset Strategy
 664
ARK Genomic Revolution UCITS ETF USD Accumulating 1.66%
Equity
World
Health Care
Innovation
 41
Amundi MSCI Disruptive Technology UCITS ETF Acc 0.02%
Equity
World
Technology
Social/Environmental
Innovation
 155
Xtrackers Russell 2000 UCITS ETF 1C 0.03%
Equity
United States
Small Cap
 1,827
SPDR MSCI All Country World Investable Market UCITS ETF (Dist) 0.00%
Equity
World
 68
UBS MSCI USA Select Factor Mix UCITS ETF USD dis 0.00%
Equity
United States
Multi-Factor Strategy
 29
UBS MSCI USA Select Factor Mix UCITS ETF hCHF acc 0.00%
Equity
United States
Multi-Factor Strategy
 32
iShares MSCI USA Small Cap ESG Enhanced CTB UCITS ETF USD (Acc) 0.01%
Equity
United States
Small Cap
 1,812
UBS MSCI USA Small Cap Selection UCITS ETF USD acc 0.04%
Equity
United States
Small Cap
 264
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.09%
Equity
United States
Health Care
Biotech
 43
iShares MSCI World Small Cap UCITS ETF 0.01%
Equity
World
Small Cap
 6,123
iShares Nasdaq US Biotechnology UCITS ETF 0.09%
Equity
United States
Health Care
Biotech
 743
SPDR MSCI USA Small Cap Value Weighted UCITS ETF 0.01%
Equity
United States
Small Cap
 704
iShares MSCI World Small Cap ESG Enhanced CTB UCITS ETF USD (Acc) 0.01%
Equity
World
Small Cap
 167
SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Dist) 0.01%
Equity
World
Small Cap
 25
HSBC MSCI World Small Cap Screened UCITS ETF USD (Acc) 0.02%
Equity
World
Small Cap
 130
SPDR Russell 2000 US Small Cap UCITS ETF 0.03%
Equity
United States
Small Cap
 3,942
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF USD Acc 0.02%
Equity
United States
Small Cap
 25
Latest articles
Popular articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.